Pay attention to the updates of 5th edition WHO classification of haematolymphoid tumours.
10.3760/cma.j.cn112151-20230822-00088
- Author:
Z WANG
1
;
X Q LI
2
Author Information
1. Department of Pathology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
2. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Neoplasms;
World Health Organization
- From:
Chinese Journal of Pathology
2024;53(1):3-5
- CountryChina
- Language:Chinese
-
Abstract:
Two review articles summarizing the fifth edition of the World Health Organization (WHO) classification of haematolymphoid tumours were officially published on Leukemia journal in 2022. This article briefly summarizes some important advances and changes in the fifth edition of WHO classification of haematolymphoid tumours, and describes how to apply the classification dialectically and reasonably in the daily practice of pathologists, so as to accurately guide clinical treatments.
